Examination study of the gastroesophageal reflux disease improvement effect by Vonoprazan to the patients with systemic sclerosis
Not Applicable
- Conditions
- Gastroesophageal reflux disease
- Registration Number
- JPRN-UMIN000024236
- Lead Sponsor
- Department of Gastroenterology Nagasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Liver and kidney dysfunction 2. Allergy to many kind of drugs. 3. Pregnant or who have a possibility to pregnancy, and under nursing patient. 4. Participation to other study in 4 months. 5. The study patient who decided to inadequacy by person in charge. 6. Administration of atazanavir sulfate and rilpivirin hydrochloryde. 7. Severe allergy or complication history of vonoprazan.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method